Average EV/EBIT Ratio
The today ev/ebit ratio is 18.39x as of Friday, June 26, 2026, shown against its trailing averages.
DGX Average EV/EBIT Ratio
DGX EV/EBIT Ratio Averages
EV/EBIT RATIO TODAY
18.39x
EV/EBIT RATIO TTM
17.88x
EV/EBIT RATIO 3Y
17.63x
EV/EBIT RATIO 5Y
14.72x
EV/EBIT RATIO 10Y
14.60x
EV/EBIT RATIO 15Y
13.28x
EV/EBIT RATIO 20Y
12.64x
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis